generic drugs

Cold and flu season is upon us. Americans spend $400 million on prescription drugs to relieve the symptoms, according to one study, and some of them spend too much. DailyFinance's Laura Rowley looks at what not to do when filling a prescription.

It's a good day to be a drugmaker after two pro-business Supreme Court rulings favored the industry. And it's an even better day for those who are counting on the EU bailing out Greece. But the folks at Google may want to search for "defense lawyers" -- they may be seeing subpoenas shortly.

It sounds illegal, but it's not: Major drug companies are essentially bribing generic rivals to delay the release of cheaper drugs, costing consumers billions of dollars a year -- and the number of these deals surged by more than 60 percent last year. According to a new report by the Federal Trade...

On Monday, Pfizer announced it would sell its Capsugel business to private-equity firm KKR for $2.375 billion. If the hints the drugmaker has been giving lately are true, the move could be the start of two years of major asset sales. Here's what's ahead for the world's biggest pharmaceutical company.

Pharmaceuticals are facing big patent cliff problems this year, but several biotechnology stocks have been doing quite well: Their biologic drugs command high prices, tend become blockbusters, and they are in far less danger from generic competition. Here are the big winners so far this year.

Generic drugs are expected to enjoy a banner year in 2011, prompting some investment pros to reformulate their portfolios to get a jump on the transition. For Goldman Sachs, that means betting on several wholesale distributors and retail drugstores that stand to benefit.

The pharmaceutical industry is ready to fall off a cliff -- a "patent cliff." Over the next few years, some of the world's most popular and lucrative medicines will go off patent, and generic competition will siphon an estimated quarter of a trillion dollars from drugmakers' bottom lines.

#fivemin-widget-blogsmith-image-987252{display:none;} .cke_show_borders #fivemin-widget-blogsmith-image-987252, #postcontentcontainer #fivemin-widget-blogsmith-image-987252{width:620px;height:439px;display:block;}As the economy still muddles through a funk, the price of prescription drugs continues...

Many consumers have yet to take advantage of the low prices for prescription drugs offered by many retailers. For example, some American consumers still pay an average of $50 a month for the generic drug pravastatin to lower cholesterol. But you can buy a 30-day supply for $4 at Target or Walmart...

What is preventing the French pharmaceutical group and U.S. biotech from reaching a merger agreement?